[Ip-health] TOWARDS A HEALTH R&D CONVENTION Opportunities, Challenges and the way ahead

Gopa Kumar kumargopakm at gmail.com
Mon Jul 9 08:52:41 PDT 2012


Sorry for that. The meeting is taking place at Third  Peoples' Health
Assembly , Capetown , ( 6-11 July 2012)

On Mon, Jul 9, 2012 at 9:00 PM, Ruth Lopert <ruth.lopert at gmail.com> wrote:

> Can I suggest that when items like this are posted that the poster
> indicate the address and the city and country in which they are being held?
> Just a thought
>
> On Mon, Jul 9, 2012 at 9:11 AM, Gopa Kumar <kumargopakm at gmail.com> wrote:
>
>> *TOWARDS A HEALTH R&D CONVENTION *
>>
>> *Opportunities, Challenges and the way ahead *
>>
>> *Workshop by Third World Network (TWN) & Drugs for Neglected Diseases
>> Initiative (DNDi)*
>>
>> *When: Monday, July 9, 17.00 p.m.*
>>
>> *Venue: Room C5*
>>
>>
>>
>> At this 3rd Peoples Health Assembly, Third World Network (TWN) and Drugs
>> for Neglected Diseases Initiative (DNDi) are hosting a workshop on the
>> *negotiations
>>
>> for a convention on health R&D to address the health needs of developing
>> countries*.
>>
>>
>>
>>
>> TWN and DNDi would like to invite participants at the PHA to a civil
>> society briefing on the issue and the need to engage in this ambitious
>> dream for a R&D system for developing countries.
>>
>>
>>
>> *Speakers: *
>>
>>
>>
>>
>> Amitava Guha (Chair), Sangeeta Shashikant (TWN), Pascale Boulet (DNDi),
>> Tim
>> Reed (Health Action International) Leena Menghaney (MSF Access Campaign).
>> Followed by Questions and panel discussion
>>
>>
>>
>> *Background:* The vast majority of health products are developed with a
>>
>> research bias to respond to the needs of patients in developed countries.
>> This corresponds to unequal access to treatment for patients in developing
>> countries driven by a 10/90 R&D gap.  Less than 10 % of all health
>> research
>> is devoted to the health of 90 % of the world population, which results in
>> neglected diseases and neglected patients.
>>
>>
>>
>> This is a reflection of the currently IP driven and highly privatized R&D
>> system which in the absence of market incentives fails to put resources
>> and
>> focus into research and development (R&D) geared towards resource poor
>> countries and the needs of their people.
>>
>>
>>
>> Ten years ago, WHO started a crucial discussion about how to ensure that
>> medical innovation could also be geared toward the medical needs of people
>> in developing countries, rather than continue to be driven by commercial
>> incentives only. Finally, a WHO ‘Consultative Expert Working Group’ (CEWG)
>> in April 2012 published a high level report containing a series of
>> recommendations, among them a proposal that WHO Member States begin a
>> process towards establishing a convention on health R&D to address the
>> health needs of developing countries, under Article 19 of the WHO
>> Constitution.
>>
>>
>>
>> Civil society and developing governments do have an opportunity to get the
>> ambitious dream of the ‘need based R&D convention’ back on the agenda
>> before the 2013 Executive Board in January and the World Health Assembly
>> later in May 2013.
>>
>>
>>
>> *This workshop is aimed at:* providing a briefing on the issue; involving
>>
>> the health movement across the world in the debates around the convention
>> on health R&D; and highlighting the different negotiating positions of
>> member states of the WHO.
>> _______________________________________________
>> Ip-health mailing list
>> Ip-health at lists.keionline.org
>> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>>
>
>



More information about the Ip-health mailing list